【君圣泰医药-B(02511.HK)拟折让约12.31%发行合共最多9900万股配售股份】智通财经APP讯，君圣泰医药-B(02511.HK)发布公告，于2026年7月31日，本公司与独家配售代理订立配售协议，按配售协议的条款及条件，本公司同意发行配售股份，而独家配售代理同意作为本公司的代理，按尽力基准促使不少于六名独立承配人合共认购最多9900万股配售股份，配售价为每股配售股份2.28港元。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.